These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36502463)

  • 1. Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia.
    Bobo P; Hines JZ; Chilengi R; Auld AF; Agolory SG; Silumesii A; Nkengasong J
    Emerg Infect Dis; 2022 Dec; 28(13):S244-S246. PubMed ID: 36502463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    He D; Ali ST; Fan G; Gao D; Song H; Lou Y; Zhao S; Cowling BJ; Stone L
    Emerg Infect Dis; 2022 Sep; 28(9):1873-1876. PubMed ID: 35914516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021.
    Amponsa-Achiano K; Frimpong JA; Barradas D; Bandoh DA; Kenu E
    Emerg Infect Dis; 2022 Dec; 28(13):S232-S237. PubMed ID: 36502407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
    Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.
    Dixon MG; Reef SE; Zimmerman LA; Grant GB
    Emerg Infect Dis; 2022 Dec; 28(13):S225-S231. PubMed ID: 36502405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection].
    AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases
    Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):615-618. PubMed ID: 34619837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccine Uptake Among People Living with HIV.
    Menza TW; Capizzi J; Zlot AI; Barber M; Bush L
    AIDS Behav; 2022 Jul; 26(7):2224-2228. PubMed ID: 34994913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.
    Mattiuzzi C; Lippi G
    Eur J Public Health; 2022 Apr; 32(2):328-330. PubMed ID: 34978571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.
    Chan DPC; Wong NS; Wong BCK; Chan JMC; Lee SS
    Emerg Infect Dis; 2022 Oct; 28(10):2130-2132. PubMed ID: 36048772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic.
    Palacios R; Mathias A
    Colomb Med (Cali); 2020 Jun; 51(2):e4276. PubMed ID: 33012888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign.
    Wang J; Zhu H; Lai X; Zhang H; Huang Y; Feng H; Lyu Y; Jing R; Guo J; Fang H
    Expert Rev Vaccines; 2022 Mar; 21(3):385-395. PubMed ID: 34974779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.
    Arriola CS; Soto G; Westercamp M; Bollinger S; Espinoza A; Grogl M; Llanos-Cuentas A; Matos E; Romero C; Silva M; Smith R; Olson N; Prouty M; Azziz-Baumgartner E; Lessa FC
    Emerg Infect Dis; 2022 Dec; 28(13):S238-S243. PubMed ID: 36502444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
    Salzman MB; Huang CW; O'Brien CM; Castillo RD
    Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
    Finsterer J; Scorza FA; Scorza CA
    Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
    Cambon L; Schwarzinger M; Alla F
    Vaccine; 2022 Jan; 40(2):178-182. PubMed ID: 34863619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now.
    Weintraub RL; Subramanian L; Karlage A; Ahmad I; Rosenberg J
    Health Aff (Millwood); 2021 Jan; 40(1):33-41. PubMed ID: 33211554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign.
    Lytras T; Kontopidou F; Lambrou A; Tsiodras S
    J Med Virol; 2022 Oct; 94(10):5044-5050. PubMed ID: 35701379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of COVID-19 Vaccination Campaign in Belgian Nursing Homes on COVID-19 Cases, Hospital Admissions, and Deaths among Residents.
    Dequeker S; Callies M; Vernemmen C; Latour K; Int Panis L; Mahieu R; Noppe L; Savsin M; Duysburgh E
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.